Merck Announces Sale of Consumer Care Business to Bayer AG for $14.2 Billion
Dateline City: BOSTON Enters into Worldwide Collaboration with Bayer to Market and Develop Novel Therapies for Cardiovascular Disease Collaboration Includes a $1 Billion Up-front Payment by Merck to Bayer BOSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it has entered into a definitive agreement to sell its Merck Consumer Care (MCC) business to Bayer AG (BAYRY) for $14.2 billion. Under the terms...
Source: Merck.com - Financial News - May 6, 2014 Category: Pharmaceuticals Tags: Consumer Care News Financial News Latest News Source Type: news

Merck Announces First-Quarter 2014 Financial Results
Dateline City: WHITEHOUSE STATION, N.J. First-Quarter 2014 Non-GAAP EPS of $0.88, Excluding Certain Items; GAAP EPS of $0.57; Confirms 2014 Full-Year Non-GAAP EPS Target of $3.35 to $3.53, Excluding Certain Items; GAAP EPS Range of $2.15 to $2.47 Worldwide Sales were $10.3 Billion, a Decrease of 4 Percent, Reflecting Unfavorable Impact of Patent Expiries and a 2 Percent Unfavorable Impact from Foreign Exchange Strategic Initiatives Drove Cost R...
Source: Merck.com - Financial News - April 29, 2014 Category: Pharmaceuticals Tags: Financial News Latest News Source Type: news

Merck To Present At Cowen Healthcare Conference
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J., Mar. 4, 2014 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck is scheduled to present at the Cowen Healthcare Conference in Boston on March 5, 2014 at 9:20 a.m. EST. Language: English Ticker Slug: Ticker: MRK Exchange: NYSE Contacts ...
Source: Merck.com - Financial News - March 4, 2014 Category: Pharmaceuticals Tags: Cowen Healthcare Financial Merck MRK Financial News Source Type: news

Merck to Present at the Credit Suisse Healthcare Conference
Dateline City: WHITEHOUSE STATION, N.J Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the Credit Suisse Healthcare Conference, Scottsdale, Arizona on Tuesday, Nov. 12, 2013 at 3:30pm [MST]. Investors, analysts, members of the media and the general public are invited to join a live webcast of the presentation at: http://www.merck.com/investors/events-and-presentations/home.html. About Merck Today's Merck is a global healt...
Source: Merck.com - Financial News - November 11, 2013 Category: Pharmaceuticals Tags: Credit Suisse Kellogg Merck MRK MSD Financial News Source Type: news